drugset / Trial / NCT00798889

Rollover Protocol for Prior SU011248 Protocols

NCT00798889

Completed 314 enrolled Pfizer
NaSingle-groupOpen-labelTreatment

Summary

The objective of this protocol is to provide SU011248 treatment for patients who have participated in a SU011248 protocol and are eligible to enter this protocol

Timeline

Start
2004-03
Primary completion
2011-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Sunitinib Small molecule Oral

Indications